299 related articles for article (PubMed ID: 26577301)
1. Seed migration after transperineal interstitial prostate brachytherapy by using loose seeds: Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) multi-institutional cohort study.
Nakano M; Yorozu A; Saito S; Sugawara A; Maruo S; Kojima S; Kikuchi T; Fukushima M; Dokiya T; Yamanaka H
Radiat Oncol; 2015 Nov; 10():228. PubMed ID: 26577301
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy.
Hirose K; Aoki M; Sato M; Akimoto H; Hashimoto Y; Imai A; Kamimura N; Kawaguchi H; Hatayama Y; Fujioka I; Tanaka M; Ohyama C; Takai Y
Radiat Oncol; 2017 Dec; 12(1):192. PubMed ID: 29191234
[TBL] [Abstract][Full Text] [Related]
3. The retrospective analysis of the relationship between prescribed dose and risk factor for seed migration in iodine-125 prostate brachytherapy.
Hirose K; Aoki M; Sato M; Akimoto H; Hashimoto Y; Imai A; Kamimura N; Kawaguchi H; Hatayama Y; Fujioka I; Tanaka M; Ohyama C; Takai Y
Jpn J Radiol; 2016 Nov; 34(11):718-723. PubMed ID: 27631882
[TBL] [Abstract][Full Text] [Related]
4. Prediction of seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds.
Sugawara A; Nakashima J; Shigematsu N; Kunieda E; Kubo A
Brachytherapy; 2009; 8(1):52-6. PubMed ID: 19154979
[TBL] [Abstract][Full Text] [Related]
5. Urinary and Rectal Toxicity Profiles After Permanent Iodine-125 Implant Brachytherapy in Japanese Men: Nationwide J-POPS Multi-institutional Prospective Cohort Study.
Ohashi T; Yorozu A; Saito S; Tanaka N; Katayama N; Kojima S; Maruo S; Kikuchi T; Dokiya T; Fukushima M; Yamanaka H
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):141-9. PubMed ID: 26279031
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors of rectal toxicity after permanent iodine-125 seed implantation: Prospective cohort study in 2339 patients.
Katayama N; Yorozu A; Maruo S; Kojima S; Ohashi T; Tanaka N; Kikuchi T; Higashide S; Saito S; Dokiya T; Fukushima M; Yamanaka H
Brachytherapy; 2016; 15(6):736-745. PubMed ID: 27720311
[TBL] [Abstract][Full Text] [Related]
7. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
[TBL] [Abstract][Full Text] [Related]
8. Genitourinary toxicity after permanent iodine-125 seed implantation: The nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS).
Tanaka N; Yorozu A; Kikuchi T; Higashide S; Kojima S; Ohashi T; Katayama N; Nakamura K; Saito S; Dokiya T; Fukushima M;
Brachytherapy; 2019; 18(4):484-492. PubMed ID: 31072729
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported health-related quality of life up to three years after the treatment with permanent brachytherapy: Outcome of the large-scale, prospective longitudinal study in Japanese-Prostate Cancer Outcome Study by Permanent I-125 Seed Implantation (J-POPS).
Koga H; Naito S; Ishiyama H; Yorozu A; Saito S; Kojima S; Higashide S; Kikuchi T; Nakamura K; Dokiya T; Fukushima M;
Brachytherapy; 2019; 18(6):806-813. PubMed ID: 31378511
[TBL] [Abstract][Full Text] [Related]
10. Comparison between high and low source activity seeds for I-125 permanent seed prostate brachytherapy.
Masucci GL; Donath D; Tétreault-Laflamme A; Carrier JF; Hervieux Y; Larouche RX; Bahary JP; Taussky D
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):781-6. PubMed ID: 20171808
[TBL] [Abstract][Full Text] [Related]
11. Migration of prostate brachytherapy seeds to the vertebral venous plexus.
Nakano M; Uno H; Gotoh T; Kubota Y; Ishihara S; Deguchi T; Hayashi S; Matsuo M; Tanaka O; Hoshi H
Brachytherapy; 2006; 5(2):127-30. PubMed ID: 16644468
[TBL] [Abstract][Full Text] [Related]
12. Comparison of implant quality between intraoperatively built custom-linked seeds and loose seeds in permanent prostate brachytherapy using sector analysis.
Katayama N; Takemoto M; Takamoto A; Ihara H; Katsui K; Ebara S; Nasu Y; Kanazawa S
J Radiat Res; 2016 Jul; 57(4):393-9. PubMed ID: 26976125
[TBL] [Abstract][Full Text] [Related]
13. Radioactive seed migration after prostate brachytherapy with iodine-125 using loose seeds versus stranded seeds.
Franca CA; Vieira SL; Carvalho AC; Bernabe AJ; Penna AB
Int Braz J Urol; 2009; 35(5):573-9; discussion 579-80. PubMed ID: 19860936
[TBL] [Abstract][Full Text] [Related]
14. Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS).
Saito S; Ito K; Yorozu A; Aoki M; Koga H; Satoh T; Ohashi T; Shigematsu N; Maruo S; Kikuchi T; Kojima S; Dokiya T; Fukushima M; Yamanaka H
Int J Clin Oncol; 2015 Apr; 20(2):375-85. PubMed ID: 24840041
[TBL] [Abstract][Full Text] [Related]
15. Reduction of pulmonary migration of permanent interstitial sources in patients undergoing prostate brachytherapy.
Stone NN; Stock RG
Urology; 2005 Jul; 66(1):119-23. PubMed ID: 15992909
[TBL] [Abstract][Full Text] [Related]
16. Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS): first analysis on survival.
Ito K; Saito S; Yorozu A; Kojima S; Kikuchi T; Higashide S; Aoki M; Koga H; Satoh T; Ohashi T; Nakamura K; Katayama N; Tanaka N; Nakano M; Shigematsu N; Dokiya T; Fukushima M;
Int J Clin Oncol; 2018 Dec; 23(6):1148-1159. PubMed ID: 29934842
[TBL] [Abstract][Full Text] [Related]
17. Prostate implant dosimetric outcomes and migration patterns between bio-absorbable coated and uncoated brachytherapy seeds.
Sarkar A; Donavanik V; Zhang I; Chen H; Koprowski C; Hanlon A; Mourtada F; Strasser J; Raben A
Brachytherapy; 2013; 12(4):356-61. PubMed ID: 23477885
[TBL] [Abstract][Full Text] [Related]
18. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
19. Incidence of seed migration to the chest, abdomen, and pelvis after transperineal interstitial prostate brachytherapy with loose (125)I seeds.
Sugawara A; Nakashima J; Kunieda E; Nagata H; Mizuno R; Seki S; Shiraishi Y; Kouta R; Oya M; Shigematsu N
Radiat Oncol; 2011 Oct; 6():130. PubMed ID: 21974959
[TBL] [Abstract][Full Text] [Related]
20. Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patients.
Shiraishi Y; Yorozu A; Ohashi T; Toya K; Seki S; Yoshida K; Kaneda T; Saito S; Nishiyama T; Hanada T; Shigematsu N
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e127-33. PubMed ID: 21398047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
